taprostene

Modify Date: 2024-01-09 12:59:59

taprostene Structure
taprostene structure
Common Name taprostene
CAS Number 108945-35-3 Molecular Weight 398.492
Density 1.3±0.1 g/cm3 Boiling Point 609.4±55.0 °C at 760 mmHg
Molecular Formula C24H30O5 Melting Point N/A
MSDS N/A Flash Point 209.2±25.0 °C

 Use of taprostene


Taprostene (CG-4203) is a synthetic, chemically stable analogue of Prostacyclin (PGI2). Taprostene exhibits endothelium and myocardial protecting actions after acute myocardial ischemia and reperfusion in cats. Taprostene enhances cytoprotective actions, while minimizing unwanted hemodynamic effects[1].

 Names

Name Taprostene
Synonym More Synonyms

 taprostene Biological Activity

Description Taprostene (CG-4203) is a synthetic, chemically stable analogue of Prostacyclin (PGI2). Taprostene exhibits endothelium and myocardial protecting actions after acute myocardial ischemia and reperfusion in cats. Taprostene enhances cytoprotective actions, while minimizing unwanted hemodynamic effects[1].
Related Catalog
Target

Prostaglandin Receptor[1]

In Vivo Taprostene (100 ng/kg/min) is infused intravenously starting 30 minutes postocclusion of the left anterior descending coronary artery followed by reperfusion 1 hour later in a 6-hour model of myocardial ischemia (MI) with reperfusion in anesthetized cats. Taprostene infusion results in significantly lower plasma creatine phosphokinase activities for the MI + Taprostene group compared with the MI + vehicle group.Taprostene has a profile of activity including prevention of aggregation in cat platelets15 at concentrations that are much lower than that required to produce significant vasodilator activity in rabbit aortic rings. In addition to antiaggregatory and cytoprotective effects in circulatory shock, Taprostene exerts beneficial effects in acute inflammatory states and in rat models of myocardial hypoxia and permanent ischemia.A variety of infusion rates of Taprostene from 50 to 200 ng/kg/min were initially used to obtain an infusion rate that produced minimal hemodynamic (i.e., vasodilator) effects but still exerted cardioprotective effects. Taprostene treatment inhibits neutrophils adhering to the myocardial endothelium in both jeopardized and necrotic myocardial tissue after ischemia and reperfusion[1]. Animal Model: Adult male cats (2.5-3.5 kg)[1] Dosage: 100 ng/kg Administration: Infused intravenously at a rate of 100 ng/kg/min until the end of the experiment (i.e., for 5.5 hours). Result: In six cat aortic rings, 1-100 ng/mL failed to exert any vasorelaxant effect. Relaxed the vascular rings 34% at 300 ng/mL. The EC50 was 520 ng/mL, a value 26 times that of its antiplatelet aggregatory effect in cat platelet-rich plasma.
References

[1]. G Johnson 3rd, et al. Endothelium and myocardial protecting actions of Taprostene, a stable prostacyclin analogue, after acute myocardial ischemia and reperfusion in cats. Circ Res. 1990 May;66(5):1362-70.

 Chemical & Physical Properties

Density 1.3±0.1 g/cm3
Boiling Point 609.4±55.0 °C at 760 mmHg
Molecular Formula C24H30O5
Molecular Weight 398.492
Flash Point 209.2±25.0 °C
Exact Mass 398.209320
PSA 86.99000
LogP 3.78
Vapour Pressure 0.0±1.8 mmHg at 25°C
Index of Refraction 1.670

 Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
DG5658000
CHEMICAL NAME :
Benzoic acid, 3-((4-(3-cyclohexyl-3-hydroxy-1-propenyl)hexahydro-5- hydroxy-2H-cyclopenta (b) furan-2-ylidene)methyl)-, (3aR-(2Z,3a-alpha,4-alpha(1E,3S*),5-beta,6a-alpha))-
CAS REGISTRY NUMBER :
108945-35-3
LAST UPDATED :
199509
DATA ITEMS CITED :
1
MOLECULAR FORMULA :
C24-H30-O5
MOLECULAR WEIGHT :
398.54

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Mammal - dog
DOSE/DURATION :
28 gm/kg/4W-I
TOXIC EFFECTS :
Gastrointestinal - ulceration or bleeding from small intestine Gastrointestinal - ulceration or bleeding from large intestine Gastrointestinal - other changes
REFERENCE :
ETPAEK Experimental and Toxicologic Pathology. (Gustav Fischer Verlag Jena, Postfach 100537, D-07705 Jena, Germany) V.44- 1992- Volume(issue)/page/year: 46,71,1994

 Synonyms

3-[(Z)-{(3aR,4R,5R,6aS)-4-[(1E,3S)-3-Cyclohexyl-3-hydroxy-1-propen-1-yl]-5-hydroxyhexahydro-2H-cyclopenta[b]furan-2-ylidene}methyl]benzoic acid
[3aR-[2Z,3aa,4a(1E,3S*)-5b,6aa]]-3-[[4-(3-Cyclohexyl-3-hydroxy-1-propenyl)hexahydro-5-hydroxy-2H-cyclopenta[b]furan-2-ylidene]methyl]benzoic acid
a-[(2Z,3aR,4R,5R,6aS)-4-[(1E,3S)-3-Cyclohexyl-3-hydroxypropenyl]hexahydro-5-hydroxy-2H-cyclopenta[b]furan-2-ylidene]-m-toluic acid
[(5Z,13E,9a,11a,15S)-2,3,4-Trinor-1,5-inter-m-phenylene-6,9-epoxy-11,15-dihydroxy-15-cyclohexyl-16,17,18,19,20-pentanor]prosta-5,13-dienoic acid
Benzoic acid, 3-[(Z)-[(3aR,4R,5R,6aS)-4-[(1E,3S)-3-cyclohexyl-3-hydroxy-1-propen-1-yl]hexahydro-5-hydroxy-2H-cyclopenta[b]furan-2-ylidene]methyl]-
taprostene
Top Suppliers:I want be here


Get all suppliers and price by the below link:

taprostene suppliers

taprostene price